Literature DB >> 8486328

[Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

H Kollaritsch1, H Holst, P Grobara, G Wiedermann.   

Abstract

BASIC REMARKS: Among travellers to distant countries with a low socioeconomic status and poor hygiene, traveller's diarrhea is a major problem. Once this epidemiological fact had been recognized, intensive efforts were made to reduce the incidence of this illness by prophylactic medication. Among non-antibiotic substances investigated, Saccharomyces boulardii (SB) appeared to show promising results in earlier studies.
METHOD: In a placebo-controlled, double-blind study, various dosages (250 mg and 1,000 mg SB) were administered prophylactically to 3,000 Austrian travellers to distant regions.
RESULTS: A significant reduction in the incidence of diarrhea was observed, with success depending directly on the rigorous use of the preparation. A tendency was noted for SB to have a varying regional effect, which was particularly marked in North Africa and in the Near-east (Turkey!); in addition, the effect also proved to be dose-dependent. The medication can be classified as low on side effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486328

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


  31 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.

Authors:  S J M Ten Bruggencate; S A Girard; E G M Floris-Vollenbroek; R Bhardwaj; T A Tompkins
Journal:  Eur J Clin Nutr       Date:  2014-11-05       Impact factor: 4.016

Review 3.  [Treating travelers' diarrhea. When should medication be given?].

Authors:  G Birkenfeld
Journal:  Internist (Berl)       Date:  2007-12       Impact factor: 0.743

Review 4.  Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives.

Authors:  Jean-Paul Buts
Journal:  Dig Dis Sci       Date:  2008-06-05       Impact factor: 3.199

Review 5.  Travellers' diarrhoea - pros and cons of different prophylactic measures.

Authors:  Angelika Wagner; Ursula Wiedermann
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

Review 6.  The Traveling Microbiome.

Authors:  Mark S Riddle; Bradley A Connor
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

Review 7.  Effects of Saccharomyces boulardii on intestinal mucosa.

Authors:  Jean-Paul Buts; Nadine De Keyser
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

Review 8.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

9.  Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.

Authors:  Fariborz Mansour-Ghanaei; Najaf Dehbashi; Kamyar Yazdanparast; Afshin Shafaghi
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.